EU drug agency: No indication AstraZeneca shot caused clots
Emer Cooke said Tuesday that the agency is "firmly convinced" that the benefits of the AstraZeneca shot outweigh the risks, but an evaluation is ongoing.

Emer Cooke said Tuesday that the agency is "firmly convinced" that the benefits of the AstraZeneca shot outweigh the risks, but an evaluation is ongoing.
Cooke said experts are meeting this week to discuss the available information and will make a recommendation Thursday.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.